Atherosclerosis Treatment Drugs Market- Regional Analysis
On the basis of region, the global atherosclerosis treatment drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America is expected to gain significant market share over the forecast period, owing to increasing incidences of atherosclerotic condition among the population in this region. For instance, in November 2016, as per data provided by the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), there were more than 15.5 million Americans who had coronary artery disease and it is expected that for every 42 seconds an American will experience the onset of a myocardial infarction.
Furthermore, Asia Pacific is expected to witness significant growth in the market, owing to expansion of major key players in this region. For instance, in October 2017, GSK opened its new regional headquarters for Asia in Singapore. The GSK’s purpose for building headquarters is to support the pharmaceutical, vaccines, and consumer healthcare businesses across multiple regions in Asia Pacific.
Atherosclerosis Treatment Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients